Citius Pharmaceuticals, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held by Citius Pharmaceuticals, Inc. on February 9, 2021. The company is incorporated in Nevada and its common stock (CTXR) and warrants (CTXRW) trade on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
The primary material event was the election of seven directors to the Board of Directors for a one-year term. All nominees received overwhelming support with zero votes against. Additionally, stockholders ratified the selection of Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ending September 30, 2021.
| Nominee | Votes For | Votes Against | Votes Withheld | Broker Non-Votes |
|---|---|---|---|---|
| Myron Holubiak | 19,311,446 | 0 | 64,378 | 16,760,405 |
| Leonard Mazur | 19,312,410 | 0 | 63,414 | 16,760,405 |
| Suren Dutia | 19,303,596 | 0 | 72,228 | 16,760,405 |
| Carol Webb | 19,314,831 | 0 | 60,993 | 16,760,405 |
| Dr. William Kane | 19,312,365 | 0 | 63,459 | 16,760,405 |
| Howard Safir | 19,307,788 | 0 | 68,036 | 16,760,405 |
| Dr. Eugene Holuka | 19,312,532 | 0 | 63,292 | 16,760,405 |
Auditor Ratification Vote: 35,707,251 For; 242,327 Against; 186,651 Abstaining.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Seven directors were elected to the Board for a one-year term expiring in 2022.
- Wolf & Company, P.C. was ratified as the independent auditor for the fiscal year ending September 30, 2021.
- Broker non-votes were significant (16,760,405 shares) for the director elections, indicating a large portion of shares held by brokers did not vote on these matters.
- No financial performance data is included in this specific filing.